Clinical trial
A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183…
NCT00234169 · Peter MacCallum Cancer Centre, Australia, Other · Completed
Key facts
| NCT number | NCT00234169 |
|---|---|
| Title | A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone |
| Official title | A Phase I/II Study of Peripheral Blood Progenitor Cells Mobilisation With VTP195183 Plus G-CSF Compared to Mobilisation With G-CSF Alone in Patients With Multiple Myeloma and Lymphoma. |
| Lead sponsor | Peter MacCallum Cancer Centre, Australia, Other |
| Collaborators | The Leukemia and Lymphoma Society |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Lymphoma |
| Intervention type | Drug |
| Interventions | VTP195183 |
| Enrollment | 30 |
| Start date | Oct 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Oct 6, 2005 |
| Last update posted | May 10, 2012 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: